Inventor · disambiguated record
Brett P. Monia
Also filed as: COWSERT LEX M · FREIER SUSAN M · MONIA BRETT · MONIA BRETT P
148 granted patents·147 pending applications·7,464 citations·filing 1992–2024
99Inventor score
Files withISIS PHARMACEUTICALS INC156MONIA BRETT P22IONIS PHARMACEUTICALS INC20BHANOT SANJAY14BENNETT C F10
Top patents by PatentIndex Score
295 records- 0199US7015315B1Gapped oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1995·Granted Mar 21, 2006·409 cites·30 claims
- 0299US6287860B1Antisense inhibition of MEKK2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 11, 2001·334 cites·14 claims
- 0398US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0498US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 0598US7732590B2Modulation of diacylglycerol acyltransferase 2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 8, 2010·132 cites·31 claims
- 0698US7709630B2Antisense modulation of connective tissue growth factor expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted May 4, 2010·131 cites·23 claims
- 0798US6524854B1Antisense inhibition of PKA regulatory subunit RII alpha expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 25, 2003·126 cites·27 claims
- 0898US6326199B1Gapped 2′ modified oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 4, 2001·282 cites·20 claims
- 0998US6210892B1Alteration of cellular behavior by antisense modulation of mRNA processingISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·358 cites·31 claims
- 1098US5623065AGapped 2' modified oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1992·Granted Apr 22, 1997·662 cites·19 claims
- 1197US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 1297US7148204B2Antisense modulation of bcl-x expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Dec 12, 2006·145 cites·16 claims
- 1397US6383808B1Antisense inhibition of clusterin expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted May 7, 2002·99 cites·13 claims
- 1496US9695418B2Oligomeric compounds comprising bicyclic nucleosides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 4, 2017·36 cites·17 claims
- 1596US8697860B1Diagnosis and treatment of diseaseISIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 15, 2014·25 cites·16 claims
- 1696US7919472B2Enhanced antisense oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·37 cites·20 claims
- 1796US6258601B1Antisense modulation of ubiquitin protein ligase expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 10, 2001·75 cites·16 claims
- 1896US6172216B1Antisense modulation of BCL-X expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 9, 2001·399 cites·35 claims
- 1996US6033910AAntisense inhibition of MAP kinase kinase 6 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Mar 7, 2000·176 cites·20 claims
- 2096US5958773AAntisense modulation of AKT-1 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Sep 28, 1999·202 cites·12 claims
- 2195US9399774B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 26, 2016·13 cites·40 claims
- 2295US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 2395US7563884B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 21, 2009·67 cites·28 claims
- 2495US6451991B1Sugar-modified gapped oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1997·Granted Sep 17, 2002·244 cites·14 claims
- 2595US6133246AAntisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 17, 2000·262 cites·3 claims
- 2694US9340784B2Methods and compositions for modulating alpha-1-antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2013·Granted May 17, 2016·11 cites·14 claims
- 2794US8334372B2Modulation of factor 11 expressionFREIER SUSAN M·Filed 2009·Granted Dec 18, 2012·21 cites·57 claims
- 2893US8586554B2Compounds and methods for modulating expression of PTP1BBHANOT SANJAY·Filed 2007·Granted Nov 19, 2013·13 cites·45 claims
- 2993US8258289B2Modulation of diacylglycerol acyltransferase 2 expressionBHANOT SANJAY·Filed 2010·Granted Sep 4, 2012·20 cites·24 claims
- 3093US6900187B2TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modificationsUNIV BRITISH COLUMBIA·Filed 2002·Granted May 31, 2005·37 cites·11 claims
- 3193US6358932B1Antisense oligonucleotide inhibition of raf gene expressionISIS PHARMACETICALS INC·Filed 2000·Granted Mar 19, 2002·64 cites·10 claims
- 3293US6331399B1Antisense inhibition of tert expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 18, 2001·42 cites·32 claims
- 3393US6159697AAntisense modulation of Smad7 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 12, 2000·49 cites·10 claims
- 3493US6100090AAntisense inhibition of PI3K p85 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Aug 8, 2000·137 cites·21 claims
- 3593US5955589AGapped 2' modified oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1995·Granted Sep 21, 1999·127 cites·15 claims
- 3692US9816092B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·7 cites·8 claims
- 3792US6809193B2Antisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 26, 2004·33 cites·2 claims
- 3892US6410518B1Antisense oligonucleotide inhibition of raf gene expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jun 25, 2002·26 cites·7 claims
- 3992US6284538B1Antisense inhibition of PTEN expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 4, 2001·38 cites·32 claims
- 4092US6184212B1Antisense modulation of human mdm2 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·78 cites·20 claims
- 4192US5656612AAntisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 1995·Granted Aug 12, 1997·99 cites·3 claims
- 4292US5563255AAntisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 1994·Granted Oct 8, 1996·77 cites·12 claims
- 4391US7884086B2Conjugates for use in hepatocyte free uptake assaysISIS PHARMACEUTICALS INC·Filed 2005·Granted Feb 8, 2011·21 cites·17 claims
- 4491US6884787B2Antisense modulation of transforming growth factor-beta 3 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Apr 26, 2005·28 cites·12 claims
- 4591US6806258B2Antisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Oct 19, 2004·20 cites·2 claims
- 4691US6046049AAntisense modulation of PI3 kinase p110 delta expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 4, 2000·88 cites·25 claims
- 4791US5576208AAntisense oligonucleotide inhibition of the RAS geneISIS PHARMACEUTICALS INC·Filed 1994·Granted Nov 19, 1996·151 cites·4 claims
- 4890US9796976B2Methods and compositions for modulating alpha-1 antitrypsin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·3 cites·18 claims
- 4990US6391636B1Antisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted May 21, 2002·89 cites·11 claims
- 5090US6214986B1Antisense modulation of bcl-x expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 10, 2001·86 cites·50 claims
Showing the top 50 of 295 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →